Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial - Wikidata - thesis-toulmin - TriplyDB

Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial

Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial

http://www.wikidata.org/entity/Q28252554

about

Unconventional anticancer agents: a systematic review of clinical trials Which botanicals or other unconventional anticancer agents should we take to clinical trial?Recent advances in the field of anti-cancer immunotherapy Clinical practice guidelines on the evidence-based use of integrative therapies during and after breast cancer treatment.Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals Chemoradiotherapy with or without AE-941 in stage III non-small cell lung cancer: a randomized phase III trial.Fighting fire with fire: is it time to use probiotics to manage pathogenic bacterial diseases?Targeting angiogenesis with integrative cancer therapies.Murine RAW 264.7 cell line as an immune target: are we missing something?Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross- sectional study Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study The Use of Complementary and Alternative Medicine among Lebanese Adults: Results from a National Survey Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1.Complementary and alternative medicine use and its association with quality of life among Lebanese breast cancer patients: a cross-sectional study.A Methodological Framework for Evaluating the Evidence for Complementary and Alternative Medicine (CAM) for Cancer Validation of single-item linear analog scale assessment of quality of life in neuro-oncology patients.Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.Antiangiogenic agents in natural products for the treatment of gynecologic disorders.What the shark immune system can and cannot provide for the expanding design landscape of immunotherapy.New approaches to selectively target cancer-associated matrix metalloproteinase activity.Poorly differentiated soft tissue sarcoma in an Arabian carpet shark Chiloscyllium arabicum (Gubanov): A case report.

P2860

Q24545903-9CAB4450-18F3-4D63-BE0A-2D349D2658F1 Q24652544-36051725-4C9D-4363-B5CA-A46F369429AA Q26775602-8B7492A8-4FCB-4790-B66F-16CE1AC3E164 Q30234688-3723FC48-9CE2-4EE0-B5C3-1C4DA4AA785F Q33910457-3E6BD01B-C738-4BDC-8D1B-CF85B0F8FA61 Q33988445-3C414AE3-8EC1-45E8-85BD-4EB216D2CB18 Q34286137-6999F0DC-CAA8-4668-AAA1-A790317D58BD Q34495463-9A717A90-05FF-4CB2-844B-9D6416AE0955 Q34550509-95910D5B-D9C4-48C6-8DD1-74DB89079A3B Q34554124-05C73813-CE78-4728-BBA6-96261CBDFCC1 Q35160044-1E34196E-005C-4FF9-B6B8-78398103CCB7 Q35708417-FB8130E5-64B9-4497-AA30-F03AF3F982CD Q35840331-96AA91AC-AD0B-4C23-BCE1-071C2373B5CB Q35874992-5FB701B1-B19A-4C13-A848-522DE8F1A1DD Q37129825-6D1F2753-921A-4C66-AF9A-AC7D6337F113 Q37319009-795F71EA-BDEF-476A-B076-79653550D7CA Q37412311-B84CE6D7-6B3F-4C39-94E6-D322FFCC29F6 Q38177316-69F97BC8-DCDE-4BDC-BFCE-B87498EF066C Q38212365-69BA69E6-BA5B-46F0-BC39-8C2B26AA2600 Q38261141-E3C66665-67E1-4863-B387-A8F71664FB62 Q48126031-1F2D1049-61D8-4CF0-9FA2-9166AC3F3BFB

P2860

Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial

http://www.wikidata.org/entity/Q28252554

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Evaluation of shark cartilage ...... l Cancer Treatment Group trial

@ast

Evaluation of shark cartilage ...... l Cancer Treatment Group trial

@en

Evaluation of shark cartilage ...... l Cancer Treatment Group trial

@nl

type

label

Evaluation of shark cartilage ...... l Cancer Treatment Group trial

@ast

Evaluation of shark cartilage ...... l Cancer Treatment Group trial

@en

Evaluation of shark cartilage ...... l Cancer Treatment Group trial

@nl

prefLabel

Evaluation of shark cartilage ...... l Cancer Treatment Group trial

@ast

Evaluation of shark cartilage ...... l Cancer Treatment Group trial

@en

Evaluation of shark cartilage ...... l Cancer Treatment Group trial

@nl

P1433

Q28252554-B0C1DFFF-EBC3-4F84-873E-B4A3BCE2A331

P1476

Q28252554-EF0406CF-E383-4D6C-B744-44228A26F087

P2093

Q28252554-03D253CB-32EF-42B0-90B5-BB1AF88BF54A

Q28252554-1017BFDC-1D54-412D-8EB3-669A8F84B391

Q28252554-4D0F59D4-32B0-4B89-B70A-713B7838C8F7

Q28252554-4F97478A-B2B2-4D04-9D3B-1B4F36550C41

Q28252554-5D63D044-7A9E-444B-9963-67C3C32BEC9E

Q28252554-6E9E1709-F25B-47E4-9593-A37BF9831FC9

Q28252554-7F4AF000-EA7E-4025-8617-01010B772C29

Q28252554-8FB6973C-CF3D-4DCC-9677-931017FCE455

Q28252554-97274D22-A568-4347-94CA-18C8EDD6B214

Q28252554-9A2A48F2-B94F-4E9C-A894-01091A40ECED

P304

Q28252554-09C88D5E-EFD7-4AC4-B4AB-9F5D09D2BFB0

P31

Q28252554-DEB15A54-5AF4-484B-AA43-1A051F8964F5

P356

Q28252554-C01ACB2B-E4AF-4642-AA21-EB980FE8E309

P407

Q28252554-76F1E035-8B2B-4486-8A56-71DB0C804681

P433

Q28252554-73BAD562-4108-4D91-82F1-280D8B7A8724

P478

Q28252554-8D81A57B-2103-45C4-B243-3A33B4CB0BFC

P577

Q28252554-459CA4D8-ECDF-4CD0-87FE-BE0414CC70A2

P5875

Q28252554-4A4BE3EC-0D56-43D8-9E50-F42D320D36B0

P698

Q28252554-54353432-1626-422A-9557-B6D5AB4E5F6D

P921

Q28252554-01ECE985-8A33-4E76-B9CF-3B438CE60087

P356

P1433

P1476

Evaluation of shark cartilage ...... l Cancer Treatment Group trial

@en

P2093

Alan R Berg

http://www.w3.org/2001/XMLSchema#string

Charles L Loprinzi

http://www.w3.org/2001/XMLSchema#string

Debra L Barton

http://www.w3.org/2001/XMLSchema#string

Denise J Smith

http://www.w3.org/2001/XMLSchema#string

Dennis F Moore

http://www.w3.org/2001/XMLSchema#string

George P Kim

http://www.w3.org/2001/XMLSchema#string

James E Krook

http://www.w3.org/2001/XMLSchema#string

Jeff A Sloan

http://www.w3.org/2001/XMLSchema#string

Kendrith M Rowland

http://www.w3.org/2001/XMLSchema#string

Miroslaw A Mazurczak

http://www.w3.org/2001/XMLSchema#string

P304

176-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.21107

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7830176

http://www.w3.org/2001/XMLSchema#string

P698

15912493

http://www.w3.org/2001/XMLSchema#string

P921